Orbital Therapeutics Stock
Orbital Therapeutics focuses on developing innovative gene therapies using a proprietary platform designed to enhance the precision and safety of viral vector-based treatments. Their technology aims to address the limitations of current gene therapy approaches, making treatments more effective for a wider range of genetic disorders and diseases.
Management Team
| Giuseppe Ciaramell, PhD Co-Founder, CEO |
| Giles Besin, PhD Chief Scientific Officer |
| Niru Subramanian COO |
| Jonahtan Piazza CFO |
| John Maraganore, PhD Chairman and Co-Founder |
| Kristina Burow Director and Co-Founder |
| Carol Suh Director and Co-Founder |
